Valuation
- Market cap
- 739,000
- Revenue TTM
- $1,890,000
- Net income TTM
- $-2,480,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -131.22%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- —
- Day's range
- $3.29 – $3.29
- Shares out
- 225,000
- Stochastic %K
- 3%
- Beta
- 1.80
- Analysts
- —
- Price target
- —
Company profile
Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 425 402 8400
- Website
- https://www.helixbiomedix.com
- Address
- 19125 Northcreek Parkway, Suite 120, Bothell, United States
Latest news
No headlines yet.
